Statistics for Gentian Diagnostics AS (id:10466 GENT)
Valuation metrics
Market cap
660.08M
Enterprise value
572.90M
Trailing P/E (ttm)
329.23
Forward P/E
26.42
PEG ratio
26.42
Price/Sales (ttm)
4.28
Price/Book (mrq)
4.09
Enterprise Value/Revenue
3.72
Enterprise Value/EBITDA
58.81
Overview
Shares outstanding
15.42M
Float
6.64M
Shares short
% Held by insiders
0.47%
% Held by institutions
0.32%
Average volume (10 days)
3.88K
Average volume (90 days)
Price summary
52-Week low
34.80
52-Week high
61.00
52-Week change
4.41%
Beta
0.56
50-Day moving average
43.55
200-Day moving average
44.56
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
1.44%
Operating margin
8.31%
Operational effectiveness
Return on assets
2.43%
Return on equity
1.40%
Income statement
Revenue (ttm)
9.99
Revenue per share (ttm)
9.99
Quarterly revenue growth (yoy)
Gross profit (ttm)
69.44M
EBITDA
6.46M
Net income to common (ttm)
2.22M
Diluted EPS (ttm)
0.13
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
93.80M
Total cash per share (mrq)
6.08
Total debt (mrq)
6.62M
Total Debt/Equity (mrq)
4.10
Current ratio (mrq)
704.10%
Book value per share (mrq)
10.47
Cash flow
Cash flow statement
31.21M
Levered free cash flow (LFCF)
17.15M